Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine Dosing for Pediatric MRI Sedation
NCT02299232Phase 4Completed
- Sponsor
- Şişli Hamidiye Etfal Training and Research Hospital
- Start
- Feb 2014
- Primary completion
- Apr 2014
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dexmedetomidine, sponsored by Şişli Hamidiye Etfal Training and Research Hospital. Started Feb 2014; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT02299232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299232.